Dumb Investment of the Week: Mallinckrodt PLC (NYSE:MNK)
On April 7, 2014, Mallinckrodt Plc, a specialty pharmaceutical company, announced it entered into an agreement to purchase Questcor Pharmaceuticals...
Continue Reading
On April 7, 2014, Mallinckrodt Plc, a specialty pharmaceutical company, announced it entered into an agreement to purchase Questcor Pharmaceuticals...
Continue Reading“I want either less corruption or more opportunity to participate in it.” --Despair.com “De-motivational” poster The quote above sums...
Continue ReadingAfter a wave of accounting and fraud scandals in 2011 (billions of investor dollars were lost), Chinese companies, particularly small...
Continue Reading